European Expansion Velocity’s ongoing Europe footprint growth and recent office expansions indicate increasing multinational trial activity and demand for regional site networks, enabling sales conversations around expanded site access, local regulatory support, and cross-border study capabilities.

Data and Tech Advantage With a technology hub in India and partnerships with Palantir and Verified Clinical Trials, Velocity emphasizes data quality, interoperability, and advanced analytics, presenting upsell opportunities for integrated data platforms, payment optimization, and streamlined trial operations.

Leadership Growth Recent executive hires and leadership changes (new Chief Revenue Officer and notable retirements) signal a focus on scaling commercial efforts, suggesting opportunities to engage on strategic partnerships, large-scale multi-site contracts, and enterprise-wide study programs.

Clinical Trial Reach Operating 70+ sites across the U.S. and Europe with 200+ investigators positions Velocity as a strong partner for sponsors seeking broad patient access, diverse site networks, and efficient patient recruitment for complex or global trials.

Oncology and New Indications Recent moves into oncology and cross-indication trial capabilities, plus collaborations for data safety and quality, open conversations around investigator networks, site readiness for oncology programs, and specialized trial services in high-need therapeutic areas.